Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07312799 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 31, 2025 (before its estimated February 11, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Addpharma Inc.
28 trials monitored
See 1 trial at risk
Hypertension
1,925 trials monitored
See 99 trials at risk
To evaluate the pharmacokinetic interactions of AD-2321, AD-2322 in healthy adult volunteers.
Trial Details
NCT Number NCT07312799
Lead Sponsor Addpharma Inc.
Conditions
(from sponsor)		 Hypertension
Related terms Hypertension
Enrollment 41 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov